Related Experiment Video
Updated: Mar 14, 2026

Application of Biolayer Interferometry BLI for Studying Protein-Protein Interactions in Transcription
Published on: July 26, 2019
Chlamydial Protease-Like Activity Factor and Type III Secreted Effectors Cooperate in Inhibition of p65 Nuclear
Michael John Patton1, Stuart McCorrister2, Chris Grant2
1Laboratory of Clinical Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Abstract:
The chlamydial protease-like activity factor (CPAF) is hypothesized to be an important secreted virulence factor; however, challenges in denaturing its proteolytic activity have hampered attempts to identify its legitimate targets. Here, we use a genetic and proteomic approach to identify authentic CPAF targets. Human epithelial cells infected with CPAF-sufficient and CPAF-deficient chlamydiae were lysed using known CPAF-denaturing conditions. Their protein profiles were analyzed using isobaric mass tags and liquid chromatography-tandem mass spectrometry. Comparative analysis of CPAF-sufficient and CPAF-deficient infections identified a limited number of CPAF host and chlamydial protein targets. Host targets were primarily interferon-stimulated gene products, whereas chlamydial targets were type III secreted proteins. We provide evidence supporting a cooperative role for CPAF and type III secreted effectors in blocking NF-κB p65 nuclear translocation, resulting in decreased beta interferon and proinflammatory cytokine synthesis. Genetic complementation of null organisms with CPAF restored p65 nuclear translocation inhibition and proteolysis of chlamydial type III secreted effector proteins (T3SEs). We propose that CPAF and T3SEs cooperate in the inhibition of host innate immunity.
Importance:
Chlamydia trachomatis is an important human pathogen responsible for over 100 million infections each year worldwide. Its success as an intracellular pathogen revolves around its ability to evade host immunity. The chlamydial protease-like activity factor (CPAF) is a conserved serine protease secreted into the host cytosol of infected cells that is thought to play an important role in immune evasion. Currently, CPAF's authentic in situ target(s) and mechanism of action in immune evasion are poorly characterized. Using a CPAF-deficient strain and high-throughput proteomics, we report novel CPAF host and chlamydial targets. Host targets were primarily interferon-stimulated genes, whereas chlamydial targets were exclusively type III secreted proteins. We propose a novel mechanism for CPAF and type III secreted proteins in the evasion of host innate immune responses. These findings provide new insights into CPAF's function as a virulence factor and a better understanding of how chlamydiae evade host immunity.
Insights
The chlamydial protease-like activity factor (CPAF) and type III secreted proteins cooperate to block host immune responses by inhibiting NF-κB signaling. This study identifies novel CPAF targets, revealing a coordinated strategy used by Chlamydia trachomatis to evade innate immunity.
Area of Science:
- Microbiology
- Immunology
- Proteomics
Background:
- Chlamydia trachomatis evades host immunity, a key factor in its success as an intracellular pathogen.
- The chlamydial protease-like activity factor (CPAF) is a secreted serine protease involved in immune evasion, but its targets and mechanisms are unclear.
- Understanding CPAF's function is crucial for insights into chlamydial virulence and host immune evasion strategies.
Purpose of the Study:
- To identify authentic in situ targets of CPAF in human epithelial cells.
- To elucidate the mechanism by which CPAF contributes to Chlamydia trachomatis immune evasion.
- To investigate the cooperative role of CPAF and type III secreted effectors in modulating host innate immunity.
Main Methods:
- Utilized a genetic approach with CPAF-sufficient and CPAF-deficient Chlamydia trachomatis strains.
- Employed high-throughput proteomics, including isobaric mass tags and LC-MS/MS, to analyze host and chlamydial protein targets.
- Investigated the impact on NF-κB p65 nuclear translocation and cytokine synthesis.
Main Results:
- Identified host targets primarily as interferon-stimulated genes and chlamydial targets as type III secreted proteins.
- Demonstrated that CPAF and type III secreted effectors cooperate to inhibit NF-κB p65 nuclear translocation.
- Showed that CPAF deficiency impairs the inhibition of host immune responses and proteolysis of type III secreted effectors.
Conclusions:
- CPAF and type III secreted effectors (T3SEs) work together to suppress host innate immunity.
- This cooperative mechanism involves blocking NF-κB signaling, leading to reduced inflammatory responses.
- The findings provide new insights into CPAF's role as a virulence factor and Chlamydia's immune evasion tactics.
More Related Videos
10:29Applying Fluorescence Resonance Energy Transfer FRET to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing
Published on: July 6, 2016
07:40Identification of Host Pathways Targeted by Bacterial Effector Proteins using Yeast Toxicity and Suppressor Screens
Published on: October 25, 2019
Related Concept Videos
Regulation of Nuclear Protein Sorting
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Bacterial Phylum Chlamydiae
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
TGF - β Signaling Pathway